Bloxiverz

Product NDC: 51754-1240
Requested package NDC: 51754-1240-1
11-digit product format: 517541240
Labeler code: 51754
Product ID: 51754-1240_2d69cd60-50c4-4ec3-926e-4d4756ad2c94
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: neostigmine methylsulfate
Dosage form: INJECTION
Route: INTRAVENOUS
Labeler: Exela Pharma Sciences, LLC
Application: NDA204078
Marketing category: NDA
Marketing start: 2021-03-03
Marketing end: 0000-00-00
Substance: NEOSTIGMINE METHYLSULFATE
Active strength: 1 mg/mL
Pharmacologic classes: Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	51754-1240	51754-1240-1	I	Inactivated by FDA		2026-08-11

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N204078-001	BLOXIVERZ	NEOSTIGMINE METHYLSULFATE	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-05-31
N204078-002	BLOXIVERZ	NEOSTIGMINE METHYLSULFATE	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-05-31
N204078-003	BLOXIVERZ	NEOSTIGMINE METHYLSULFATE	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2023-10-27

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 100 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS		RLD	2013-05-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2013-05-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2023-10-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2023-10-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2023-10-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2023-10-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2023-10-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2023-10-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N204078-002	BLOXIVERZ	10MG/10ML (1MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N204078-003	BLOXIVERZ	5MG/5ML (1MG/ML)	SOLUTION / INTRAVENOUS		RLD	2023-10-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N204078-001	BLOXIVERZ	5MG/10ML (0.5MG/ML)	SOLUTION / INTRAVENOUS	AP	RLD, RS	2013-05-31	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 78 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204078-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204078-002	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N204078-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204078-002	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204078-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204078-002	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204078-001	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204078-002	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204078-001	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204078-002	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204078-001	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N204078-002	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204078-001	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N204078-002	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204078-001	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N204078-002	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N204078-001	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N204078-002	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204078-001	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N204078-002	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204078-001	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N204078-002	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N204078-001	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N204078-002	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N204078-001	AP	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N204078-002	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N204078-001	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N204078-002	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N204078-001	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N204078-002	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N204078-001	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N204078-002	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N204078-001	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N204078-002	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N204078-001	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N204078-002	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N204078-001	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N204078-002	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N204078-001	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N204078-002	AP	1	`87673890dc5c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f58f10d3-5fa9-4c2e-9a6e-77029e9ed80b	Product name	1	20231002
6c2b16d0-96e9-444e-98c5-9883cd6eb72d	Product name	2	20230316
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
ad279e69-d021-f6bd-1150-2b55f23832d5	Product name	9	20211014
48747306-602a-42cc-957b-5b0c69158eee	Product name	1	20180604
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51754-1240-1	2026-01-29	C162847	48780-1	49896155-ac12-586f-e063-e6dba90add90	These highlights do not include all the information needed to use BLOXIVERZ ® safely and effectively. See full prescribing information for BLOXIVERZ. BLOXIVERZ (Neostigmine Methylsulfate Injection), for intravenous use Initial U.S. Approval: 1939

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
51754-1240-3	Bloxiverz	10 in 1 PACKAGE	INJECTION	10	2
51754-1240-3	Bloxiverz	1 in 1 CARTON	INJECTION	1	2
51754-1240-1	Bloxiverz	1 in 1 CARTON	INJECTION	1	1
51754-1240-1	Bloxiverz	10 mL in 1 VIAL, MULTI-DOSE	INJECTION	10	1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
51754-1240-1	ML - Milliliter	51754-1240	372682fa-dde2-44b7-a6ad-1f6b2684e108	1	2021-06-02
51754-1240-3	ML - Milliliter	51754-1240	befc18c9-841b-4169-9b83-f5e631b1d36a	1	2021-06-02

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51754-1240	BLOXIVERZ (NEOSTIGMINE METHYLSULFATE) INJECTION [EXELA PHARMA SCIENCES, LLC]	2	Legacy NDC, 2 package rows	20210508_1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a.zip
51754-1240	BLOXIVERZ (NEOSTIGMINE METHYLSULFATE) INJECTION [EXELA PHARMA SCIENCES, LLC]	1	Legacy NDC, 2 package rows	20210317_761d8917-27da-4a0c-9acc-98688cbc1d46.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Bloxiverz	NEOSTIGMINE METHYLSULFATE	Exela Pharma Sciences, LLC	d2f55643-2b0d-4ef9-a9d8-b7138b314372	2023-12-31	Warnings, Adverse reactions	Exact identifier application applno (NDA): 204078 application number: NDA204078

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
98IMH7M386	NEOSTIGMINE METHYLSULFATE	51-60-5	NEOSTIGMINE METHYLSULFATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1429284	Bloxiverz 1 MG/ML Injectable Solution	PSN	1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a	2
311936	neostigmine methylsulfate 1 MG/ML Injectable Solution	PSN	1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a	2
1429284	neostigmine methylsulfate 1 MG/ML Injectable Solution [Bloxiverz]	SBD	1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a	2
311936	neostigmine methylsulfate 1 MG/ML Injectable Solution	SCD	1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a	2
1429284	Bloxiverz 1 MG/ML Injectable Solution	SY	1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a	2
311936	neostigmine methylsulfate 1 MG/ML Injectable Solution	SY	1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a	2
1429284	Bloxiverz 1 MG/ML Injectable Solution	PSN	761d8917-27da-4a0c-9acc-98688cbc1d46	1
311936	neostigmine methylsulfate 1 MG/ML Injectable Solution	PSN	761d8917-27da-4a0c-9acc-98688cbc1d46	1
1429284	neostigmine methylsulfate 1 MG/ML Injectable Solution [Bloxiverz]	SBD	761d8917-27da-4a0c-9acc-98688cbc1d46	1
311936	neostigmine methylsulfate 1 MG/ML Injectable Solution	SCD	761d8917-27da-4a0c-9acc-98688cbc1d46	1
1429284	Bloxiverz 1 MG/ML Injectable Solution	SY	761d8917-27da-4a0c-9acc-98688cbc1d46	1
311936	neostigmine methylsulfate 1 MG/ML Injectable Solution	SY	761d8917-27da-4a0c-9acc-98688cbc1d46	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
51754-1240-1	51754124001	1 VIAL, MULTI-DOSE in 1 CARTON (51754-1240-1) > 10 mL in 1 VIAL, MULTI-DOSE	2021-03-03	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Bloxiverz	Exela Pharma Sciences, LLC \| Patheon Austria GmbH & Co KG	2021-03-03	HUMAN PRESCRIPTION DRUG LABEL	2
Bloxiverz	Exela Pharma Sciences, LLC	2021-03-03	HUMAN PRESCRIPTION DRUG LABEL	1